Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Cytodyn is a biotechnology business based in the US. Cytodyn stocks (CYDY.US) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.26 – the same closing value as a week prior. Cytodyn employs 23 staff and has a market cap (total outstanding stock value) of $238.8 million.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $0.26 |
|---|---|
| 52-week range | $0.15 - $1.26 |
| 50-day moving average | $0.30 |
| 200-day moving average | $0.37 |
| Wall St. target price | $4.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.19 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $0.26 from 2023-06-02
| 1 week (2023-05-30) | -3.70% |
|---|---|
| 1 month (2023-05-05) | -3.70% |
| 3 months (2023-03-06) | -23.53% |
| 6 months (2022-12-06) | -23.53% |
| 1 year (2022-06-06) | -25.71% |
|---|---|
| 2 years (2021-06-04) | -87.62% |
| 3 years (2020-06-05) | 2.83 |
| 5 years (2018-06-06) | 0.488 |
| Gross profit TTM | $-73,277,000 |
|---|---|
| Return on assets TTM | -133.19% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $-0.13 |
| Market capitalisation | $238.8 million |
TTM: trailing 12 months
We're not expecting Cytodyn to pay a dividend over the next 12 months.
Over the last 12 months, Cytodyn's shares have ranged in value from as little as $0.15 up to $1.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cytodyn's is 0.1988. This would suggest that Cytodyn's shares are less volatile than average (for this exchange).
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease ("COVID-19"). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…Compare some of the best bad credit loans in PEI.
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
